Coastline Trust Co Sells 5,886 Shares of Colgate-Palmolive Company (NYSE:CL)

Coastline Trust Co decreased its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 30.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,140 shares of the company's stock after selling 5,886 shares during the quarter. Coastline Trust Co's holdings in Colgate-Palmolive were worth $1,231,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the company. Brighton Jones LLC boosted its holdings in Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock valued at $962,000 after purchasing an additional 450 shares during the period. Bernard Wealth Management Corp. bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $36,000. Proficio Capital Partners LLC acquired a new stake in Colgate-Palmolive during the fourth quarter worth approximately $186,000. Fisher Asset Management LLC increased its stake in Colgate-Palmolive by 17.9% during the 4th quarter. Fisher Asset Management LLC now owns 72,628 shares of the company's stock worth $6,603,000 after acquiring an additional 11,005 shares during the period. Finally, Kohmann Bosshard Financial Services LLC acquired a new position in Colgate-Palmolive in the 4th quarter valued at $26,000. Institutional investors own 80.41% of the company's stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on CL shares. Piper Sandler cut their price target on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a report on Monday, March 31st. Wells Fargo & Company upped their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research note on Wednesday, April 2nd. Citigroup raised their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a report on Monday, April 28th. Barclays lowered their price target on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a report on Friday, April 11th. Finally, UBS Group raised their price objective on Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a research note on Thursday, April 17th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of "Hold" and a consensus target price of $101.69.

Colgate-Palmolive Trading Down 0.7%

Shares of Colgate-Palmolive stock traded down $0.65 on Thursday, hitting $91.75. The stock had a trading volume of 3,300,939 shares, compared to its average volume of 4,804,615. The stock has a 50 day moving average of $90.66 and a 200 day moving average of $90.56. The firm has a market capitalization of $74.36 billion, a P/E ratio of 25.92, a PEG ratio of 4.91 and a beta of 0.37. Colgate-Palmolive Company has a twelve month low of $85.32 and a twelve month high of $109.30. The company has a debt-to-equity ratio of 8.96, a quick ratio of 0.54 and a current ratio of 0.85.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.05. The firm had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The company's revenue was down 3.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.86 EPS. Sell-side analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive declared that its board has approved a share buyback program on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to purchase up to 6.8% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's board of directors believes its shares are undervalued.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be given a $0.52 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.27%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.76%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.